# Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye

> **NCT00471419** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 750 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Rimexolone

## Key facts

- **NCT ID:** NCT00471419
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2012-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471419, "Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00471419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*